HR 2821
  • Introduced
    Apr 10, 2025
  • Passed House
  • Passed Senate
  • Became Law
HR 2821
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
FDA Modernization Act 3.0
Last Action See all actions
Senate • Jul 21, 2026: Received in the Senate.
Latest Bill Text See all bill texts
Engrossed in House

Summary

Comments on HR 2821

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Jul 21, 2026 | Senate
    • Received in the Senate.
  • Jul 20, 2026 | House
    • Mr. Guthrie moved to suspend the rules and pass the bill.
    • Considered under suspension of the rules. (consideration: CR H4639-4640)
    • DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
    • Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
    • On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
    • Motion to reconsider laid on the table Agreed to without objection.
  • Jun 18, 2026 | House
    • Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
    • Placed on the Union Calendar, Calendar No. 614.
  • May 21, 2026 | House
    • Committee Consideration and Mark-up Session Held
    • Ordered to be Reported by the Yeas and Nays: 44 - 0.
  • May 13, 2026 | House
    • Subcommittee Consideration and Mark-up Session Held
    • Forwarded by Subcommittee to Full Committee by Voice Vote.
  • Apr 10, 2026 | House
    • Referred to the Subcommittee on Health.
  • Apr 10, 2025 | House
    • Introduced in House
    • Referred to the House Committee on Energy and Commerce.
Bill Texts
Documents
Looks like we don't have any documents available at this moment.
Sources